CN Stock MarketDetailed Quotes

Hubei Jumpcan Pharmaceutical (600566)

Watchlist
  • 25.90
  • -1.19-4.39%
15min DelayMarket Closed Aug 7 15:00 CST
23.87BMarket Cap13.74P/E (TTM)

Hubei Jumpcan Pharmaceutical (600566) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
2021/Q9
2021/H1
Total Operating Revenue
-20.84%1.21B
-22.43%6.22B
-32.27%3.93B
-31.87%2.75B
-36.51%1.53B
-16.96%8.02B
-11.19%5.81B
-12.84%4.03B
+0.60%2.40B
+7.32%9.65B
+10.91%6.54B
+19.82%4.63B
+9.87%2.39B
+17.90%9.00B
+8.96%5.89B
+4.92%3.86B
+13.43%2.17B
+23.77%7.63B
+25.39%5.41B
+24.76%3.68B
Operating Revenue
-20.84%1.21B
-22.43%6.22B
-32.27%3.93B
-31.87%2.75B
-36.51%1.53B
-16.96%8.02B
-11.19%5.81B
-12.84%4.03B
+0.60%2.40B
+7.32%9.65B
+10.91%6.54B
+19.82%4.63B
+9.87%2.39B
+17.90%9.00B
+8.96%5.89B
+4.92%3.86B
+13.43%2.17B
+23.77%7.63B
+25.39%5.41B
+24.76%3.68B
Other Operating Revenues
----
-30.77%14.11M
----
-57.72%4.57M
----
+23.44%20.38M
----
+47.42%10.80M
----
-16.90%16.51M
----
-31.03%7.33M
----
+52.79%19.87M
----
+67.91%10.63M
----
-8.77%13.00M
----
-7.09%6.33M
Total Operating Cost
-24.69%832.97M
-20.00%4.31B
-25.58%2.89B
-24.82%2.04B
-30.62%1.11B
-17.31%5.39B
-12.97%3.88B
-15.43%2.72B
-6.58%1.59B
-1.57%6.52B
+5.79%4.46B
+13.82%3.21B
+7.26%1.71B
+12.93%6.62B
+4.56%4.21B
+2.69%2.82B
+9.92%1.59B
+24.07%5.86B
+24.07%4.03B
+25.44%2.75B
Cost of Sales
-37.80%215.85M
-21.33%1.31B
-22.55%932.61M
-18.88%668.45M
-23.52%347.01M
-6.75%1.66B
+0.63%1.20B
-3.07%823.98M
+5.67%453.70M
+16.04%1.78B
+17.63%1.20B
+31.27%850.08M
+24.99%429.36M
+20.43%1.54B
+10.68%1.02B
+4.03%647.58M
+6.90%343.51M
+12.94%1.28B
+15.61%919.11M
+18.83%622.50M
Operating Tax Surcharges
-30.65%19.66M
-15.98%112.91M
-18.82%75.33M
-15.21%53.92M
-26.81%28.35M
-8.11%134.39M
-6.77%92.79M
-9.95%63.59M
+7.23%38.74M
+5.35%146.24M
+7.42%99.53M
+17.58%70.62M
+6.15%36.13M
+14.81%138.81M
+6.05%92.65M
+0.15%60.06M
+12.18%34.03M
+21.03%120.90M
+24.60%87.36M
+28.21%59.97M
Operating Expense
-25.48%415.60M
-28.55%2.11B
-38.89%1.34B
-39.33%976.86M
-43.65%557.67M
-26.27%2.95B
-19.44%2.19B
-19.55%1.61B
-9.14%989.65M
-2.58%4.01B
+2.43%2.72B
+10.12%2.00B
+3.14%1.09B
+10.74%4.11B
+0.76%2.65B
+0.18%1.82B
+9.23%1.06B
+23.40%3.71B
+29.63%2.63B
+30.18%1.81B
Administrative Expenses
+13.52%115.71M
+3.55%448.01M
+7.51%323.85M
+10.56%209.60M
+11.11%101.92M
+16.06%432.65M
+7.99%301.23M
+4.82%189.58M
+9.37%91.74M
+2.34%372.78M
+8.95%278.95M
+7.74%180.87M
+7.36%83.88M
+14.94%364.24M
+12.45%256.03M
+13.99%167.88M
+8.39%78.12M
+9.27%316.89M
+10.62%227.69M
+14.86%147.27M
Research and Development
+5.83%106.83M
-13.42%385.10M
-8.42%271.85M
-8.79%189.89M
-11.62%100.95M
-4.22%444.78M
-11.28%296.86M
-3.19%208.20M
+7.12%114.22M
-16.07%464.40M
+32.50%334.60M
+24.14%215.06M
+12.92%106.63M
+5.70%553.30M
+14.54%252.53M
+18.64%173.24M
+20.24%94.43M
+114.74%523.44M
+20.54%220.47M
+19.04%146.02M
Financial Expense
-36.43%-40.68M
+77.37%-54.49M
+73.41%-54.61M
+68.73%-55.73M
+68.20%-29.81M
+6.47%-240.83M
-20.60%-205.39M
-69.82%-178.20M
-142.36%-93.77M
-200.23%-257.49M
-191.61%-170.31M
-142.18%-104.93M
-155.61%-38.69M
+3.60%-85.76M
-0.45%-58.40M
-5.79%-43.33M
+30.13%-15.14M
-85.06%-88.97M
-56.46%-58.14M
-73.59%-40.96M
-Interest Financial Expense
+75.81%6.17M
-58.03%11.45M
-58.62%9.41M
-55.56%7.06M
-53.53%3.51M
+55.10%27.27M
+127.75%22.75M
+142.17%15.88M
+157.75%7.55M
-42.18%17.58M
-61.35%9.99M
-62.13%6.56M
-66.02%2.93M
-12.86%30.41M
+0.10%25.84M
+2.26%17.32M
+5.39%8.62M
+5.66%34.90M
+4.75%25.81M
+2.62%16.93M
-Interest Financial Income
-39.81%-47.01M
+75.18%-66.82M
+71.73%-64.75M
+67.46%-63.35M
+66.90%-33.63M
+2.48%-269.22M
-26.56%-229.02M
-73.90%-194.66M
-142.83%-101.60M
-135.97%-276.08M
-113.25%-180.96M
-83.29%-111.94M
-74.48%-41.84M
+5.98%-117.00M
-0.58%-84.86M
-5.01%-61.07M
+19.98%-23.98M
-52.38%-124.45M
-35.62%-84.37M
-44.06%-58.16M
Credit Impairment Loss
+26.39%47.22M
-121.85%-4.86M
-56.28%22.62M
-57.92%20.95M
-9.93%37.36M
+590.06%22.26M
+21.43%51.75M
+36.29%49.80M
+66.66%41.48M
+108.86%3.23M
+530.00%42.61M
+184.85%36.54M
+184.88%24.89M
-348.81%-36.39M
+15.93%6.76M
+7287.88%12.83M
+977.50%8.74M
-29.87%-8.11M
+140.36%5.83M
-98.89%173.63K
Asset Impairment Loss
----
+83.55%-474.14K
---1.14M
---1.14M
--1.20K
---2.88M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Fair Value Change Income
+61.22%19.30M
-58.35%41.31M
-79.80%17.46M
-162.52%-32.51M
-26.26%11.97M
+579.28%99.20M
+456.47%86.46M
+148.76%52.00M
-22.62%16.23M
+299.63%14.60M
-30.76%15.54M
+9.55%20.90M
+27.36%20.98M
-106.39%-7.32M
-35.87%22.44M
-5.74%19.08M
+6.30%16.47M
+447.02%114.55M
+148.39%34.99M
+165.05%20.24M
Investment income
-10.32%25.71M
+127.30%189.89M
+409.96%156.70M
+733.03%131.62M
+94.47%28.67M
+2.22%83.54M
-59.91%30.73M
-69.22%15.80M
-47.20%14.74M
+23.43%81.72M
+86.92%76.64M
+227.35%51.33M
+5342.07%27.93M
+40.94%66.21M
+27.74%41.00M
-15.80%15.68M
-108.14%-532.73K
+3337.85%46.98M
+497.19%32.10M
+414.88%18.62M
-Investment Income Associates
----
----
----
----
----
----
----
----
----
+219.34%2.46M
----
----
----
+14.08%769.49K
----
----
----
+375.51%674.51K
----
----
Asset Deal Income
----
-12.35%173.23K
-56.79%81.33K
+1545.16%68.41K
----
+51.71%197.64K
+86.45%188.21K
-105.07%-4.73K
-106.37%-5.94K
-97.50%130.28K
-98.52%100.94K
-98.62%93.33K
+1509.03%93.33K
+698.58%5.22M
+1033.04%6.82M
+18664.17%6.78M
-118.34%-6.62K
-80.48%653.30K
+1272.60%601.56K
-17.60%36.11K
Other Revenues
+25.23%6.28M
-25.32%24.16M
-41.01%14.96M
-62.32%8.70M
-3.54%5.02M
+58.77%32.35M
+121.44%25.37M
+205.03%23.10M
+11.72%5.20M
+1.17%20.37M
-30.40%11.46M
-33.64%7.57M
+50.50%4.66M
+84.30%20.14M
+94.99%16.46M
+113.43%11.41M
-1.46%3.09M
+8.67%10.93M
-0.31%8.44M
+11.07%5.35M
Operating Profit
-5.83%473.05M
-24.63%2.16B
-40.79%1.26B
-42.83%833.43M
-43.30%502.32M
-12.13%2.86B
-4.72%2.12B
-4.86%1.46B
+16.52%885.93M
+34.44%3.26B
+25.51%2.22B
+38.56%1.53B
+24.55%760.34M
+25.39%2.42B
+21.39%1.77B
+13.14%1.11B
+23.35%610.47M
+31.58%1.93B
+33.30%1.46B
+23.51%977.35M
Add:Non-operating Income
-90.63%1.19M
-84.08%18.60M
-84.56%17.77M
-84.93%16.71M
-87.75%12.74M
+180.47%116.80M
+219.23%115.10M
+241.89%110.90M
+240.81%103.97M
-56.62%41.64M
-61.47%36.06M
-63.39%32.44M
-62.05%30.51M
+370.94%95.99M
+558.23%93.57M
+551.88%88.60M
+664.74%80.38M
-4.30%20.38M
-31.60%14.22M
-9.84%13.59M
Less:Non-operating Expense
-82.23%69.96K
+876.53%14.09M
+889.83%12.49M
+5.69%1.09M
+291.43%393.74K
-46.37%1.44M
+8.39%1.26M
-51.98%1.03M
-92.47%100.59K
-76.75%2.69M
-86.44%1.16M
-73.62%2.15M
-82.12%1.34M
+317.07%11.57M
+544.40%8.58M
+918.05%8.16M
+3666.71%7.47M
-58.95%2.77M
-67.38%1.33M
-77.09%801.79K
Gross Profit
-7.87%474.17M
-27.40%2.16B
-43.57%1.26B
-45.84%849.04M
-48.00%514.67M
-9.67%2.98B
-1.15%2.23B
+0.33%1.57B
+25.37%989.79M
+31.47%3.30B
+21.64%2.26B
+31.72%1.56B
+15.53%789.51M
+28.58%2.51B
+26.10%1.86B
+19.80%1.19B
+35.27%683.38M
+31.47%1.95B
+32.46%1.47B
+23.32%990.14M
Less:Income tax
+2.35%75.10M
-13.03%383.99M
-27.55%236.29M
-45.33%123.76M
-48.69%73.38M
-6.06%441.54M
+4.47%326.15M
+2.70%226.36M
+28.43%143.00M
+39.80%470.03M
+18.16%312.20M
+29.48%220.41M
+9.26%111.35M
+44.16%336.20M
+31.08%264.21M
+24.90%170.23M
+54.17%101.92M
+13.05%233.22M
+32.15%201.56M
+15.34%136.29M
Net Profit
-9.57%399.07M
-29.90%1.78B
-46.31%1.02B
-45.93%725.29M
-47.89%441.29M
-10.27%2.54B
-2.06%1.91B
-0.06%1.34B
+24.87%846.79M
+30.18%2.83B
+22.22%1.95B
+32.09%1.34B
+16.63%678.16M
+26.47%2.17B
+25.31%1.59B
+18.99%1.02B
+32.42%581.46M
+34.45%1.72B
+32.51%1.27B
+24.70%853.85M
Net Profit from Continuing Operations
-9.57%399.07M
-29.90%1.78B
-46.31%1.02B
-45.93%725.29M
-47.89%441.29M
-10.27%2.54B
-2.06%1.91B
-0.06%1.34B
+24.87%846.79M
+30.18%2.83B
+22.22%1.95B
+32.09%1.34B
+16.63%678.16M
+26.47%2.17B
+25.31%1.59B
+18.99%1.02B
+32.42%581.46M
+34.45%1.72B
+32.51%1.27B
+24.70%853.85M
Less:Minority Profit
-212.36%-1.08M
-92.01%411.46K
-63.39%1.65M
-69.14%921.90K
-37.09%956.76K
+20.33%5.15M
+40.18%4.52M
+34.92%2.99M
+8.59%1.52M
+341.93%4.28M
+165.02%3.22M
+418.17%2.21M
+407.82%1.40M
+149.45%968.89K
+350.42%1.22M
--427.25K
--275.78K
---1.96M
---485.48K
----
Net Profit of Parent Company Owners
-9.13%400.14M
-29.77%1.78B
-46.27%1.02B
-45.87%724.36M
-47.91%440.34M
-10.32%2.53B
-2.13%1.90B
-0.11%1.34B
+24.90%845.27M
+30.04%2.82B
+22.11%1.94B
+31.93%1.34B
+16.44%676.76M
+26.27%2.17B
+25.17%1.59B
+18.94%1.02B
+32.36%581.19M
+34.60%1.72B
+32.56%1.27B
+24.70%853.85M
Basic EPS
-8.33%0.44
-30.07%1.93
-46.38%1.11
-46.21%0.78
-47.83%0.48
-10.39%2.76
-2.50%2.07
-0.89%1.45
+24.49%0.92
+26.23%3.08
+18.47%2.12
+28.00%1.46
+13.00%0.74
+25.77%2.44
+25.14%1.79
+18.94%1.14
+32.39%0.65
+26.80%1.94
+21.67%1.43
+14.40%0.96
Diluted EPS
-8.33%0.44
-30.07%1.93
-46.38%1.11
-46.21%0.78
-47.83%0.48
-10.39%2.76
-2.31%2.07
-0.75%1.45
+24.49%0.92
+28.87%3.08
+19.92%2.12
+29.52%1.46
+15.11%0.74
+25.13%2.39
+24.61%1.77
+18.61%1.13
+31.29%0.64
+24.84%1.91
+20.48%1.42
+13.21%0.95
Total Composite Income
-9.57%399.07M
-29.90%1.78B
-46.31%1.02B
-45.93%725.29M
-47.89%441.29M
-10.27%2.54B
-2.06%1.91B
-0.06%1.34B
+24.87%846.79M
+30.18%2.83B
+22.22%1.95B
+32.09%1.34B
+16.63%678.16M
+26.47%2.17B
+25.31%1.59B
+18.99%1.02B
+32.42%581.46M
+34.45%1.72B
+32.51%1.27B
+24.70%853.85M
Total Composite Income of Parent Company Owners
-9.13%400.14M
-29.77%1.78B
-46.27%1.02B
-45.87%724.36M
-47.91%440.34M
-10.32%2.53B
-2.13%1.90B
-0.11%1.34B
+24.90%845.27M
+30.04%2.82B
+22.11%1.94B
+31.93%1.34B
+16.44%676.76M
+26.27%2.17B
+25.17%1.59B
+18.94%1.02B
+32.36%581.19M
+34.60%1.72B
+32.56%1.27B
+24.70%853.85M
Total Composite Income of Minority Owners
-212.36%-1.08M
-92.01%411.46K
-63.39%1.65M
-69.14%921.90K
-37.09%956.76K
+20.33%5.15M
+40.18%4.52M
+34.92%2.99M
+8.59%1.52M
+341.93%4.28M
+165.02%3.22M
+418.17%2.21M
+407.82%1.40M
+149.45%968.89K
+350.42%1.22M
--427.25K
--275.78K
---1.96M
---485.48K
----
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY2021/Q92021/H1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights